AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System April 12th, 2021 Announcements
AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance March 30th, 2021 Announcements
AngioDynamics to Participate in a Virtual Fireside Chat at the KeyBanc Life Sciences & MedTech Investor Forum March 15th, 2021 Announcements
AngioDynamics to Participate in a Virtual Fireside Chat at the Oppenheimer Healthcare Conference March 9th, 2021 Announcements
AngioDynamics Appoints Richard C. Rosenzweig Senior Vice President, General Counsel and Secretary, Promotes Juan Carlos Serna to Senior Vice President, Scientific & Clinical Affairs February 1st, 2021 Announcements
